MYND Life Sciences Inc. filed its Annual on Apr 28, 2023 for the period ending Oct 31, 2022. In this report its auditor, Meyers Norris Penny LLP - MNP LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.04 CAD | +33.33% |
|
0.00% | 0.00% |
1st Jan change | Capi. | |
---|---|---|
0.00% | 1.05M | |
+16.90% | 122B | |
+21.64% | 116B | |
+22.18% | 27.03B | |
-21.55% | 20.36B | |
-16.89% | 16.43B | |
-18.87% | 15.91B | |
-44.74% | 15.6B | |
+61.95% | 14.94B | |
+2.61% | 13.59B |
- Stock Market
- Equities
- MYND Stock
- News MYND Life Sciences Inc.
- MYND Life Sciences Inc. Auditor Raises 'Going Concern' Doubt